Biofourmis lands $100M in Series C funding round

The Company will use funding to bring new digital therapeutic solutions to market

Stethoscope on a computer keyboard

Biofourmis, which combines AI-based data analytics with medical-grade biosensors to provide personalized, predictive care, announced it’s completed a $100 million Series C financing round. SoftBank Vision Fund 2 led the funding round, with existing investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI participating too.

Biofourmis closed its $35 million Series B funding round just a year ago and has since increased its revenue significantly through new partnerships with seven pharmaceutical companies and 10 health systems worldwide, including Novartis, AstraZeneca and Mayo Clinic. 

Biofourmis says it will use the funding to develop, validate and bring new digital therapeutic solutions for cardiology, respiratory, oncology and pain treatments to the market. The company also plans to focus on the U.S. and Asian markets, including Asia Pacific, China and Japan.

Biofourmis CEO Kuldeep Singh Rajput said, "Our vision is to use digital medicine to empower patients, clinicians and researchers everywhere by providing software-as-a-treatment for patients with unmet clinical needs, from post-acute care to optimal medication therapy.”

“With this new funding, we will accelerate our global expansion, advance our digital therapeutics pipeline, develop additional care pathways and drive deeper integration with our health system, hospital, pharmaceutical and clinical research clients and partners," Kuldeep added.

Biofourmis also announced an alignment of its internal operations. The new business structure will include two verticals: Biofourmis Therapeutics, which will focus on developing clinically validated software-based therapeutics and Biofourmis Health, which will leverage the company's AI-based remote monitoring system to lower health care costs and improve patient outcomes.

"In the last seven months, healthcare has fast-forwarded by at least five years," Rajput said. "Despite a challenging global economic environment due to the COVID-19 pandemic, we expect that our latest funding round will accelerate Biofourmis' plans to rapidly scale to support more healthcare provider, pharmaceutical and health plan clients across the world. We will continue to drive an evolution toward a more personalized and predictive remote method of care delivery that patients prefer and that enables better outcomes."

Featured Resources

Five lessons learned from the pivot to a distributed workforce

Delivering continuity and scale with a remote work strategy

Download now

Connected experiences in a digital transformation

Enable businesses to meet the demands of the future

Download now

Simplify to secure

Reduce complexity by integrating your security ecosystem

Download now

Enhance the safety and security of your people, assets and operations

Enable a true vision of security with an engineered solution based on hyperconverged and storage platforms

Download now

Recommended

Google and Amwell team up to boost telehealth services
Cloud

Google and Amwell team up to boost telehealth services

25 Aug 2020
Infermedica raises $10.25 million in Series A funding
communications

Infermedica raises $10.25 million in Series A funding

6 Aug 2020
Robots are supposed to steal our jobs – so why haven’t they during the coronavirus crisis?
artificial intelligence (AI)

Robots are supposed to steal our jobs – so why haven’t they during the coronavirus crisis?

13 Jul 2020
Crowdfunded investment company launches $100M pandemic fund
Technology

Crowdfunded investment company launches $100M pandemic fund

3 Jun 2020

Most Popular

Accenture ploughs $3 billion into cloud migration support group
digital transformation

Accenture ploughs $3 billion into cloud migration support group

17 Sep 2020
16 ways to speed up your laptop
Laptops

16 ways to speed up your laptop

16 Sep 2020
Google Pixel 4a review: A picture-perfect package
Google Android

Google Pixel 4a review: A picture-perfect package

18 Sep 2020